Professor & Director Hsien-Yuan Lane, MD, PhD has been devoted to clinical and translational research for brain disorders for decades, and have been leading in clinical studies on NMDA receptor (NMDAR)-related biomarkers and enhancer, such as sodium benzoate (the pivotal D-amino acid oxidase [DAAO] inhibitor), for early detection and treatment of schizophrenia and other brain disorders with cognitive dysfunction. I have got encouraging findings; and several papers have been published on first-rate journals, including JAMA Psychiatry, Molecular Psychiatry, Biological Psychiatry, JAMA Network Open, and Psychiatry and clinical neurosciences.